German Registry of Alzheimer's Disease Treated With Transcranial Pulse Stimulation - Trial NCT06313944
Access comprehensive clinical trial information for NCT06313944 through Pure Global AI's free database. This phase not specified trial is sponsored by Heinrich-Heine University, Duesseldorf and is currently Not yet recruiting. The study focuses on Alzheimer Disease. Target enrollment is 100 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Heinrich-Heine University, Duesseldorf
Timeline & Enrollment
N/A
Apr 01, 2024
Oct 01, 2026
Primary Outcome
Number of (Serious) Adverse Events,Number of adverse device effects
Summary
This study will primarily investigate the safety and secondarily the effect and applicability
 of Transcranial Pulse Wave Stimulation (TPS) for the treatment of Alzheimer's disease in the
 context of a PMCF study (Post-Market Clinical Follow-up). The multicenter, prospective data
 collection should help to optimize the stimulation protocol, as well as to record frequent to
 occasional adverse effects of the product and cognitive, affective and subjective scores.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06313944
Non-Device Trial